期刊
JOURNAL OF BIOLOGICAL CHEMISTRY
卷 297, 期 4, 页码 -出版社
ELSEVIER
DOI: 10.1016/j.jbc.2021.101180
关键词
-
资金
- NIH National Heart, Lung, and Blood Institute [R01-HL064357]
- United States Department of Veterans Affairs Biomedical Laboratory Research and Development Service [IK2BX003628]
The study revealed that lysoPC activates PLA(2) to release AA from cellular membrane, opening arachidonate-regulated calcium channels and promoting TRPC6 activation, which affects EC migration and healing during vascular interventions.
During vascular interventions, oxidized low-density lipoprotein and lysophosphatidylcholine (lysoPC) accumulate at the site of arterial injury, inhibiting endothelial cell (EC) migration and arterial healing. LysoPC activates canonical transient receptor potential 6 (TRPC6) channels, leading to a prolonged increase in intracellular calcium ion concentration that inhibits EC migration. However, an initial increase in intracellular calcium ion concentration is required to activate TRPC6, and this mechanism remains elusive. We hypothesized that lysoPC activates the lipid-cleaving enzyme phospholipase A(2) (PLA(2)), which releases arachidonic acid (AA) from the cellular membrane to open arachidonate-regulated calcium channels, allowing calcium influx that promotes externalization and activation of TRPC6 channels. The focus of this study was to identify the roles of calcium-dependent and/or calcium independent PLA(2) in lysoPC-induced TRPC6 externalization. We show that lysoPC induced PLA(2) enzymatic activity and caused AA release in bovine aortic ECs. To identify the specific subgroup and the isoform(s) of PLA(2) involved in lysoPCinduced TRPC6 activation, transient knockdown studies were performed in the human endothelial cell line EA.hy926 using siRNA to inhibit the expression of genes encoding cPLA(2)alpha , cPLA(2)gamma , iPLA(2)beta , or iPLA(2)gamma. Downregulation of the beta isoform of iPLA(2) blocked lysoPC-induced release of AA from EC membranes and TRPC6 externalization, as well as preserved EC migration in the presence of lysoPC. We propose that blocking TRPC6 activation and promoting endothelial healing could improve the outcomes for patients undergoing cardiovascular interventions.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据